Artificial intelligence is rapidly entering hospital workflows, promising earlier diagnoses, improved efficiency, and better patient outcomes. From predictive alerts to automated documentation, AI-powered tools are being marketed as solutions to some of healthcare’s most persistent challenges. Hospitals across the United States are adopting these technologies at an accelerating pace, often under pressure to modernize operations and improve quality metrics. AI should support clinical judgment by identifying patterns in patient data that may be difficult for humans to detect in real time. But the reality inside hospitals is more complicated. Many AI tools reach clinical environments with limited independent validation, and their performance can change dramatically once exposed to the messy complexity of real patient care. Understanding how to evaluate these tools, monitor their performance, and hold vendors accountable is becoming an essential skill for healthcare organizations.

The Regulatory Gap: How Clinical AI Reaches Hospitals

Most clinicians assume that any software used in patient care has undergone rigorous clinical testing before deployment. Many AI tools enter hospital systems through regulatory pathways that require far less evidence than frontline staff might expect. In the United States, the majority of AI-enabled medical software is cleared through the FDA’s 510(k) pathway, which allows devices to be approved if they are considered substantially equivalent to an existing product rather than requiring new prospective clinical trials.

This approach can accelerate innovation, but it also means hospitals may implement AI systems with limited real-world evidence supporting their performance. Reviews of AI-enabled medical devices authorized by the FDA have found that a significant portion lacked publicly available clinical validation data at the time of approval. Tools associated with later safety concerns or recall events had never undergone independent clinical trials before being introduced into clinical settings.

For hospital administrators, this regulatory structure shifts a portion of the evaluation responsibility downstream to healthcare institutions themselves. Instead of assuming regulatory clearance guarantees clinical effectiveness, hospitals must treat AI tools as technologies that require local validation, continuous monitoring, and workflow testing after deployment.

For nurses and physicians working at the bedside, understanding this regulatory context helps explain why an AI system that performs well in vendor demonstrations may behave very differently in everyday patient care. It also reinforces why structured evaluation frameworks and frontline feedback are essential to ensuring that clinical AI improves care rather than introducing new risks.

Why the Epic Sepsis Model Became a Cautionary Tale

Deployed in hundreds of hospitals nationwide, the ESM was marketed as a tool to identify sepsis earlier and improve outcomes. Then, independent researchers started testing it. A landmark external validation study found an area under the curve (AUC) of just 0.63, substantially worse than what Epic had originally reported. The model missed two-thirds of sepsis patients. When the alert threshold was applied, clinicians would need to evaluate 109 patients to identify each true sepsis case, a signal-to-noise ratio that is not just unhelpful but actively harmful to workflow. The ESM case carries several lessons that apply far beyond sepsis prediction:

1. Vendor-reported performance metrics are not a substitute for independent, local validation. A model trained on one patient population may perform very differently on yours.

2. Widespread adoption is not evidence of effectiveness; hundreds of hospitals implemented the ESM before its shortcomings were publicly documented.

3. The clinicians who flagged concerns about the model's performance were identifying a real problem months before the peer-reviewed evidence caught up.

A Practical Evaluation Framework for Clinical Staff

Before Implementation: Questions to Ask Vendors

When your hospital is considering a new AI tool, clinical staff should have a seat at the table during evaluation. Nurses must be included in impact predictions and risk assessments for clinical AI models. Here are the questions worth pressing on:

• What is the clinical evidence? Ask whether the tool has been validated in a setting similar to yours: same patient demographics, acuity levels, and care delivery model. Peer-reviewed, independently conducted studies carry more weight than vendor white papers. If the vendor cannot point to external validation, that is a significant red flag.

• What data was the training set built on? AI models inherit the biases of their training data. A model trained predominantly on data from large academic medical centers may underperform in community hospitals, rural facilities, or populations with different demographic profiles. The FAIR-AI framework specifically warns that hasty deployment can introduce or amplify health inequities.

• What is the false positive rate? This question is particularly important for alert-generating tools. A tool with a high false positive rate does not just miss its mark — it actively degrades care by contributing to alert fatigue. Research shows that clinicians in some ICU settings face 187 alerts per patient per day, and the vast majority of clinical decision support alerts are overridden, including those flagged as critical.

• How will performance be monitored post-deployment? A responsible vendor will have a plan for ongoing performance monitoring, not just a launch-day demo. Ask how frequently the model is retrained, what triggers a performance review, and what data the vendor will share with your institution.

After Implementation: What to Track

Once a tool is live, evaluation shifts from theoretical to observational. Here is what clinical staff should monitor:

• Override rates. If clinicians consistently override or ignore an AI-generated recommendation, that is data. Track how often alerts are dismissed, and document the clinical reasoning behind overrides. High override rates often indicate that the tool is not calibrated to your patient population or workflow.

• Time impact. An AI tool should reduce workload, not redistribute it. If nurses are spending more time managing, correcting, or working around the tool than they would without it, the net effect on care is negative. This is especially relevant for documentation tools. Platforms like Sully.ai have demonstrated that well-designed AI can save clinicians over two hours daily by automating structured note generation, intake workflows, and follow-up coordination within existing EHR systems, but poorly implemented tools can do the opposite.

• Clinical outcome correlation. This requires coordination with quality improvement teams, but the question is straightforward: since implementing this tool, have the outcomes it was designed to improve actually improved? If a sepsis prediction tool were adopted to reduce sepsis mortality, is mortality moving in the right direction? If not, why not?

• Equity impact. Are the tool's recommendations equally accurate across patient demographics? Evaluate whether predictive models are fair, meaning they do not systematically perform worse for patients based on race, gender, age, or socioeconomic status. This is a patient safety issue.

Building Institutional Accountability: Three Layers of Oversight

Front-Line Operations

The clinicians who use AI tools daily are the first line of evaluation. This means creating structured channels for nurses and physicians to report when tools are not performing as expected. When a charge nurse documents that a predictive model consistently misflags a specific patient population, that observation should reach those with the authority to act on it.

Frontline clinicians are often the first to recognize when AI systems behave unexpectedly. Nurses and physicians interact with these tools continuously, observing how predictions align with real patient conditions and clinical judgment. Their feedback provides a level of insight that cannot be captured by algorithmic performance metrics alone.

When hospitals create structured channels for clinician feedback, small issues can be identified before they evolve into larger patient safety risks. Clinicians may notice patterns where a model consistently misidentifies certain patient populations or generates alerts at inappropriate times during care. Incorporating this feedback into model refinement allows AI systems to improve over time. Without clinician input, hospitals risk relying on technology that appears functional on paper but fails to support real clinical decision-making.

Risk Management and Performance Monitoring

A dedicated team should monitor AI tool performance on an ongoing basis, using predefined metrics established before deployment. This team should track accuracy, false-positive and false-negative rates, bias indicators, and clinical outcome correlations on a scheduled cadence — not just when a problem surfaces.

Internal Audit and Governance

The third layer provides independent verification. Insufficient governance of AI is a patient safety threat, warning that failure to develop systemwide governance for AI applications increases organizational liability and risk. An effective governance structure should include clear documentation of which AI tools are in use, their intended purpose, their measured performance, and the decision-making process that led to their adoption. If a tool is underperforming, there should be a defined process for remediation or removal.

What Nurses and Clinical Staff Can Do Right Now

The structural changes described above take time and institutional commitment. But clinical staff do not need to wait for a governance committee to start evaluating the AI tools they use every day. Here are concrete, actionable steps:

1. Document your experience systematically. One of the most valuable actions clinicians can take is systematically documenting how AI tools perform during routine care. When alerts appear incorrect, poorly timed, or irrelevant to a patient’s condition, recording the reason for disagreement creates useful evidence. The same applies to documentation tools that generate notes requiring heavy editing. Tracking how long corrections take or how often alerts are dismissed can reveal patterns that might otherwise go unnoticed. Over time, this kind of documentation transforms individual frustrations into actionable operational data.

2. Request performance data. Clinical staff have the right to understand how AI tools integrated into their workflow are performing. Asking basic questions about system metrics can reveal whether a tool is delivering meaningful value. For example, clinicians can request information about alert volume, positive predictive value, false positive rates, and recent performance evaluations. If a hospital or vendor cannot provide clear answers, that lack of transparency is itself important information. Consistent requests for measurable performance data encourage accountability and reinforce the expectation that clinical tools must demonstrate real-world effectiveness.

3. Connect with your informatics team. Nursing informatics professionals serve as a critical bridge between clinical practice and health technology systems. These specialists often translate bedside observations into actionable improvements for electronic health records, decision support tools, and AI platforms. Clinicians who maintain open communication with informatics teams can report usability issues, workflow disruptions, and unexpected system behaviors more effectively. If a hospital lacks dedicated informatics roles, advocating for their creation can significantly strengthen the organization’s ability to evaluate new technologies and ensure clinical perspectives influence technical decisions.

4. Participate in evaluation committees. Hospitals frequently rely on multidisciplinary committees to review, select, and monitor new digital tools. When clinical staff participate in these groups, they bring essential real-world insight that cannot be captured through technical metrics alone. Nurses and physicians can explain how alerts affect shift workflow, whether recommendations align with bedside observations, and how tools influence patient care decisions.

5. Know the difference between a tool that is learning and a tool that is failing. Not every imperfect AI system is inherently flawed. Some tools are designed to adapt and improve as they collect local data and incorporate clinician feedback. The key is learning to distinguish between systems that gradually improve and those that consistently perform poorly. If alerts remain inaccurate, workflows remain disrupted, or outcomes show no measurable improvement over time, the issue may not be calibration but fundamental design limitations. Recognizing this difference helps clinicians decide whether continued engagement or formal escalation is the appropriate response.

Not all vendors approach hospital AI the same way. The most responsible partners distinguish themselves through several observable behaviors.

They publish or share clinical validation data, including performance across different patient populations. They build tools designed to integrate with existing workflows rather than requiring clinicians to adapt their practice to the technology. They provide ongoing performance monitoring and are transparent about limitations. And they actively solicit clinician feedback as a mechanism for continuous improvement. Better evaluation, not just better models, is the prerequisite for trustworthy clinical AI. That principle should guide every procurement decision. Before signing a contract, ask whether the vendor's business model depends on your clinical outcomes actually improving, or just on your institution renewing the license.

The hospitals that will get the most value from AI in the coming years are not necessarily the ones that adopt the most tools. They are the ones who build the evaluative infrastructure to determine which tools work, for whom, and under what conditions, and who empower their clinical staff to be active participants in that evaluation rather than passive recipients of technology decisions made elsewhere.

Sources:

• ECRI — Ensuring Safe AI Use in Healthcare: A Governance Imperative

• Sully.ai — AI Employees for Hospitals

• Michigan Medicine — Epic Sepsis Model's Ability to Predict Depends on Hospital Factors